Stem Cells Translational Medicine

杂志介绍

Stem Cells Translational Medicine杂志介绍

《Stem Cells Translational Medicine》是一本以English为主的开放获取国际优秀期刊，中文名称干细胞转化医学，本刊主要出版、报道医学-细胞与组织工程领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为6.429，最新CiteScore 指数为13.1。

本刊近期中国学者发表的论文主要有：

• Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Stud

  Author:

• Exosome-Based Regimen Rescues Endometrial Fibrosis in Intrauterine Adhesions Via Targeting Clinical Fibrosis Biomarker

  Author:

• WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axi

  Author:

• Direct Lineage Reprogramming for Induced Keratinocyte Stem Cells: A Potential Approach for Skin Repai

  Author:

英文介绍

Stem Cells Translational Medicine杂志英文介绍

STEM CELLS Translational Medicine is a monthly, peer-reviewed, largely online, open access journal.

STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy. By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes.

The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells, including their characterization and manipulation, and the translation of their clinical aspects of from the bench to patient care. STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.